| Literature DB >> 28241785 |
Anna-Greta Mamhidir1,2, Britt-Marie Sjölund3,4, Birgitta Fläckman5, Anders Wimo4,6, Anders Sköldunger4,6, Maria Engström3,7,8.
Abstract
BACKGROUND: Chronic pain affects nursing home residents' daily life. Pain assessment is central to adequate pain management. The overall aim was to investigate effects of a pain management intervention on nursing homes residents and to describe staffs' experiences of the intervention.Entities:
Keywords: Cluster- randomized trial; Mixed-methods; Nursing homes; Pain assessment; Pain intervention
Mesh:
Year: 2017 PMID: 28241785 PMCID: PMC5330015 DOI: 10.1186/s12877-017-0454-z
Source DB: PubMed Journal: BMC Geriatr ISSN: 1471-2318 Impact factor: 3.921
Fig. 1Program logic assumption with measured outcomes showed in bold
Fig. 2Study design
Fig. 3Flow chart of randomizing units and participants
Characteristics of participants in the intervention and comparison groups (N = 213) at baseline (T0)
| Characteristics | Intervention group ( | Comparison group ( |
|
|---|---|---|---|
| Age in years, n 130/83, mean (SD) | 85.5 (6.7) | 85.1 (7.2) | 0.694g |
| Female gender, n (%) | 93 (71.5) | 53 (63.9) | 0.239h |
| MMSEa n 130/83, md (Q1-Q3) | 11.5 (0.75–19.25) | 16 (0–21.0) | 0.756i |
| QUALIDb n 75/44, md (Q1-Q3) | 21.0 (18.0–27.0) | 24.5 (18.0–30.75) | 0.240i |
| WHO-5c wellbeing index n 56/40 md (Q1-Q3) | 60.0 (44.0–80.0) | 78.0 (57.0–88.0) | 0.003i |
| Proxy NRSd n 130/82, md (Q1-Q3) | 3.0 (1.0–6.0) | 3.0 (1.75–6.0) | 0.641i |
| Katz-ADLe n 129/83, md (Q1-Q3) | 5.0 (2.5–6.0) | 3.0 (1.0–6.0) | 0.013i |
| ADCS-ADLf sev n 79/40, md (Q1-Q3) | 10.0 (5.0–21.0) | 5.5 (3.0–12.0) | 0.032i |
aMini-Mental-State Examination (MMSE). bQualid scale: Quality of Life in Dementia Scale, an observational scale, range with minimum score 11 indicating high QOL and maximum score 55 indicating poor QOL. cWHO-5 index: WHO-5 well-being index: self-report, score from 0 (worst thinkable well-being) to 100 (best thinkable well-being). dNumeric Rating Scale: self-report, from 0 (no pain) through 10 (worst imaginable pain). eKatz index of ADLs: score from 0 to 6, higher score indicating more dependency.fADCS-ADL: Alzheimer’s Disease Cooperative Study Activities of Daily Living Scale, scale from 0 to 54 points with lower scores indicating more dependency
Md median, Q quartil, g Student’s independent t-test, h = Chi2-test, i = Mann–Whitney U-test
Changes over time, baseline (T0) and follow-up 2 (T2), in the intervention group (n = 98) and comparison group (n = 68) concerning wellbeing, proxy-pain and functional dependency
| Intervention group, median (Q1, Q3) | Within groupf | Comparison group, median (Q1, Q3) | Within groupf | Changes over time between the groupsg | |||
|---|---|---|---|---|---|---|---|
| Measurements, n intervention/comparison | T0 | T2 |
| T0 | T2 |
|
|
| QUALIDa 53/32 | 21 (17–27) | 22 (17–28) | .409 | 23.5 (17.25–29.75) | 22,5 (17.0–27.75) | .965 | .733 |
| WHO-5 wellbeing indexb 24/31 | 64 (50–80) | 68 (46–83) | .665 | 76 (56–88) | 76 (64–88) | .965 | .683 |
| Proxy-NRSc 97/67 | 3 (1.0–5.25) | 2 (0–5.5) | .396 | 3 (1–6) | 4 (1–6) | .711 | .309 |
| Katz-ADLd 98/66 | 4 (2–6) | 5 (2–6) | .638 | 3 (1–5) | 5 (2–6) |
|
|
| ADCS-ADL sev.e 60/33 | 10.5 (5–21.75) | 9 (4.25–15.75) |
| 6 (4–20.5) | 7 (5–13) | .498 | .297 |
Q quartil, aQualid scale: Quality of Life in Dementia Scale, an observational scale, range with minimum score 11 indicating high QOL and maximum score is 55 indicating poor QOL. bWHO-5 index: WHO-5 well-being index: self-report, score from 0 (worst thinkable well-being) to 100 (best thinkable well-being). cNumeric Rating Scale: self-report, from 0 (no pain) through 10 (worst imaginable pain). dKatz index of ADLs: score from 0 to 6, higher score indicating more dependency.eADCS-ADL: Alzheimer’s Disease Cooperative Study Activities of Daily Living Scale, scale from 0 to 54 points with lower scores indicating more dependency. f Wilcoxon Signed Rank-Test gMann-Whitney U-test
Parameter estimates and 95% CIs from GEE analyses for the scales, QUALID, WHO, PROXY-NRS, Katz-ADL and ADCS-ADL sev. scale
| QUALID | WHOa | PROXY-NRS | Katz-ADLa | ADCS-ADL sev | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| B |
| B |
| B |
| B |
| B |
| |
| GEE Model | ||||||||||
| Interaction time*group | 0.34 (−3.30;3.99) | 0.853 | −2.30 (−11.74;7.14) | 0.633 | −0.45 (−1.34;0.430) | 0.314 | −0.84 (−1.28;−0.41) |
| −0.55 (−2.88;1.78) | 0.643 |
| Mean differences | ||||||||||
| Intervention group T0-T1 | 0.69 (−1.12;2.49) | 0.456 | −7.52 (−15.7;0.65) | 0.071 | −0.23 (−0.81;0.34) | 0.427 | 0.06 (−0.17;0.29) | 0.617 | 0.07 (−1.50;1.64) | 0.931 |
| Intervention group T0-T2 | 0.74 (−1.41;2.89) | 0.502 | −1.00 (−8.34;6.35) | 0.790 | −0.37 (−0.99;0.25) | 0.242 | 0.02 (−0.27;0.30) | 0.908 | −1.41 (−2.80;−0.02) | 0.047 |
| Comparison group T0-T1 | 0.17 (−2.29;2.63) | 0.895 | 2.98 (−3.61;9.57) | 0.376 | −0.39 (−0.97;0.19) | 0.186 | 0.46 (0.19;0.72) |
| −0.60 (−2.16;0.96) | 0.450 |
| Comparison group T0-T2 | 0.39 (−2.55;3.34) | 0.794 | 1.30 (−4.89;7.50) | 0.680 | −0.09 (−0.72;0.55) | 0.793 | 0.86 (0.53;1.18) |
| −0.86 (−2.73;1.01) | 0.369 |
| Intervention group T0 – Comparison group T0 | −1.40 (−4.39;1.59) | 0.360 | −3.02 (−5.21;−0.83) |
| −0.092 (−0.84;0.65) | 0.808 | 0.13 (0.03;0.23) |
| 3.07 (−0.67;6.81) | 0.107 |
CIconfidence interval, bold print indicates statistically significant values, afor WHO and Katz-ADL we controlled for baseline (T0) data in the GEE models as there were significant differences between the intervention and comparison groups at baseline. QUALID scale: Quality of Life in Dementia Scale, an observational scale, range with minimum score 11 indicating high QOL and maximum score is 55 indicating poor QOL. WHO-5 index: WHO-5 well-being index: self-report, score from 0 (worst thinkable well-being) to 100 (best thinkable well-being). Numeric Rating Scale: self-report, from 0 (no pain) through 10 (worst imaginable pain). Katz index of ADLs: score from 0 to 6, higher score indicating more dependency. ADCS-ADL: Alzheimer’s Disease Cooperative Study Activities of Daily Living Scale, scale from 0 to 54 points with lower scores indicating more dependency
Change of drug use over time in the intervention and comparison groups at a group level
| Time T0 | Time T2 | |||||
|---|---|---|---|---|---|---|
| Measurements, n intervention/comparison | Intervention group, n (%) user | Comparison group, n (%) user |
| Intervention group, n (%) user | Comparison group, n (%) user |
|
| Analgetics | 99 (79.8) | 54 (72.0) | .204 | 43 (89.6) | 30 (78.9) | .171 |
| Long acting Benzodiazepines | 13 (10.5) | 10 (13.1) | .417 | 4 (8.3) | 5 (13.2) | .468 |
| Anticholinergics | 16 (12.9) | 13 (17.3) | .527 | 4 (8.4) | 4 (10.5) | .469 |
Md Q1_Q3
Results from the group interviews (T1 and T2) presented in nine subcategories and three categories
| Interviews | Quotations from the interviews | Subcategories | Categories |
|---|---|---|---|
| Group interview (T1) | ‘X: The facial expressions and the sleep X: The facial expression is the best, then you can see that wrinkle there and the whole thing, the first physical symptoms’. | The scale works well but is not always necessary | A new way of working to identify pain |
| ‘For temporary fill in personnel it is another thing entirely, the temporary staff barely know them [the residents]’. | |||
| ‘X Maybe get the staff’s interest going, so that everyone strives towards the same goal. X: What can it be when she does like that or is looking like that? When they don’t hear, or they don’t see, they can’t make themselves understood even if it’s not dementia, just as difficult’. | Helps to put a focus on pain | ||
| ‘X: Says that it’s not good today. X: It seems that he may have pain, but there is nothing you can put your finger on’. | Pain assessments can help bring about an improvement in documentation and evaluation | ||
| ‘Can’t make an evaluation after such a short time. Assessing pain can still feel like a problem because doing that is still so new to us, a person needs to train a bit more’. | A longer trial period is needed to evaluate the usefulness of the scale | ||
| Group interviews (T2) | ‘X: What do you mean, a little headache, one’s own personal views are incredibly important. X: If one accesses pain for every person, so to say, then you’ll get quite a few different responses. X: Some of the older ones have a high pain threshold, they don’t complain much’. | Be observant of pain indicators and your personal views regarding pain | A systematic method of working and better communication facilitates better pain management |
| ‘X: We have had several doctors…then there was a summer substitute and then we had a new one again. X: Feels very confusing. X: Now, we have a doctor from the local medical care centre here and he is very dedicated and good to talk to’. | Pain assessments facilitate more effective teamwork and drug treatments | ||
| ‘If a person has made an assessment and it says that someone is likely to have pain, then you have evidence with the pain assessment’. | |||
| ‘It is easier to get the staff to understand that you try other things [acetaminophen] first, it can be pain but it can also be something else that is causing the uneasiness, try something like that, to begin with before some sedative’. | |||
| ‘X: Very different, doing this pain assessment. X: It has taken a lot of time but that will probably get better, it should be easy and there are benefits with it, but of course we don’t get more time either, instead we’ll have to make time to do it’. | Usability of the scale and items and work practices | ||
| We have considered it to be extremely interesting and thought it was great fun’. | Planning phase, lectures and pain assessment use | ||
| ‘There are staff members that have questioned this, I could also say so, otherwise I would be lying but most of them are positive’. | Possibilities and obstacles with the intervention | ||
| ‘X: Really good dialogue, she checks how it’s going, knows exactly how it is’. ‘X: Has not shown interest, but I hope that they [managers] will be interested.’ | Manager support |
Nurses’ narratives are denoted with (X)